Hepatitis C Virus Diagnosis and the Holy Grail

被引：56

作者：

Applegate, Tanya L. ^{[1
]}

Fajardo, Emmanuel ^{[2
]}

Sacks, Jilian A. ^{[3
]}

机构：

[1] UNSW Sydney, Kirby Inst, High St, Sydney, NSW 2052, Australia

[2] Med Sans Frontieres Access Campaign, Rue Lausanne 78 POB 1016, CH-1211 Geneva, Switzerland

[3] Clinton Hlth Access Initiat, 383 Dorchester Ave Suite 400, Boston, MA 02127 USA

来源：

INFECTIOUS DISEASE CLINICS OF NORTH AMERICA | 2018年 / 32卷 / 02期

关键词：

HCV; Diagnostics; Simplified; Rapid; Point-of-care; Test and treat; Models of care; HCV elimination; POINT-OF-CARE; DRIED BLOOD SPOT; HCV RNA; MOLECULAR DIAGNOSTICS; VIRAL-HEPATITIS; CORE ANTIGEN; INJECT DRUGS; INFECTION; LINKAGE; DIFFERENTIATION;

D O I：

10.1016/j.idc.2018.02.010

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

The world has embraced the call for global elimination of hepatitis C virus by 2030. The unprecedented speed of therapeutic development and increased access to direct-acting antivirals has made elimination a possibility. We must screen hundreds of millions of people to diagnose and treat those currently infected. Global access to hepatitis C virus diagnostics will be a keystone to success. Key challenges must be overcome and systems optimized to ensure widespread access to existing diagnostics. Although promising technologies may soon transform the landscape, innovative strategies are needed to stimulate investment and accelerate the development of point-of-care hepatitis C virus diagnostics.

引用

页码：425 / 445

页数：21

共 131 条

[1]

AI-Hihi E, 2017, BMJ OPEN QUAL, V6

[2] Management of hepatitis C in decentralised versus centralised drug substitution programmes and minimally invasive point-of-care tests to close gaps in the HCV cascade [J].

Andrea, Bregenzer ;

Anna, Conen ;

Juerg, Knuchel ;

Andree, Friedl ;

Franz, Eigenmann ;

Martin, Naef ;

Peter, Ackle ;

Martin, Roth ;

Andreas, Fux Christoph .

SWISS MEDICAL WEEKLY, 2017, 147

[3]

[Anonymous], 2016, GUID SCREEN CAR TREA

[4]

[Anonymous], 2017, HCV GUID REC TEST MA

[5]

[Anonymous], 2016, WHO GUID HEP B C TES

[6] Eliminating hepatitis C within low-income countries - The need to cure genotypes 4, 5, 6 [J].

Asselah, Tarik ;

Hassanein, Tarek ;

Waked, Imam ;

Mansouri, Abdellah ;

Dusheiko, Geoffrey ;

Gane, Edward .

JOURNAL OF HEPATOLOGY, 2018, 68 (04) :814-826

[7]

Bajis S, 2017, AUSTR VIR HEP EL C A

[8] Interventions to enhance testing, linkage to care and treatment uptake for hepatitis C virus infection among people who inject drugs: A systematic review [J].

Bajis, Sahar ;

Dore, Gregory J. ;

Hajarizadeh, Behzad ;

Cunningham, Evan B. ;

Maher, Lisa ;

Grebely, Jason .

INTERNATIONAL JOURNAL OF DRUG POLICY, 2017, 47 :34-46

[9] Performance of rapid diagnostic tests for detection of Hepatitis B and C markers in HIV infected patients [J].

Barbosa, Jakeline Ribeiro ;

Baima Colares, Jeova Keny ;

Flores, Geane Lopes ;

Cortes, Vanessa Faria ;

Miguel, Juliana Custodio ;

Portilho, Moyra Machado ;

Marques, Vanessa Alves ;

Potsch, Denise Vigo ;

Brandao-Mello, Carlos Eduardo ;

Amendola-Pires, Marcia ;

Pilotto, Jose Henrique ;

Lima, Danielle Malta ;

Lampe, Elisabeth ;

Villar, Livia Melo .

JOURNAL OF VIROLOGICAL METHODS, 2017, 248 :244-249

[10] A pilot study of rapid hepatitis C virus testing in the Rhode Island Department of Corrections [J].

Beckwith, Curt G. ;

Kurth, Ann E. ;

Bazerman, Lauri B. ;

Patry, Emily J. ;

Cates, Alice ;

Liem Tran ;

Noska, Amanda ;

Kuo, Irene .

JOURNAL OF PUBLIC HEALTH, 2016, 38 (01) :130-137

← 1 2 3 4 5 6 7 8 9 10 →